DV
Dividend Vision

ORIC — ORIC Pharmaceuticals, Inc.

ORIC Pharmaceuticals, Inc. (ORIC)

Total return is -46.2% over the past 6.3 years, 245.4 points behind SPY at 199.2%. Its deepest 1-year drawdown was 48.1%.

ORIC Pharmaceuticals, Inc. is a healthcare equity stock that focuses on the pharmaceutical sector. As an individual company stock rather than a diversified fund, it does not have a defined dividend distribution rate, expense ratio, or regular distribution frequency. This security appeals primarily to growth-oriented investors seeking exposure to the healthcare and pharmaceutical industry rather than income-focused investors.

ORIC key facts

Asset type
Stock
Asset class
Equity
Inception date
04/24/2020
Distribution frequency
None
Last close
$13.87
Market cap
$1,437,662,336
Average volume
828629.0
Beta
0.972
Payout ratio
0.0
Forward P/E
0.0
EPS
$-1.31